ARTICLE | Clinical News
Febuxostat regulatory update
July 13, 2015 7:00 AM UTC
The European Commission approved an expanded label for Adenuric febuxostat from Menarini to include the prevention and treatment of hyperuricemia in adults undergoing chemotherapy for hematologic mali...